News
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
4h
TipRanks on MSNEli Lilly’s Promising Study on Baricitinib for Juvenile Arthritis: A Market Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
4h
TipRanks on MSNEli Lilly’s Mirikizumab Study: A Promising Step for Pediatric Ulcerative Colitis Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a ...
With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...
New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...
8h
Clinical Trials Arena on MSNAbbVie seeks Rinvoq alopecia approval after second Phase III success
If approved, AbbVie's Rinvoq could be set to dominate the alopecia market after exhibiting better efficacy than main ...
Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...
20hon MSN
Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
Thermo Fisher Scientific has opened a 375,000-square-foot, carbon-neutral site in Mebane, N.C., designed to produce 40 ...
Criminals were caught trying to import the likes of Wegovy and Mounjaro in 'large-scale' smuggling operations.
The lawsuit alleges civil violations of the Racketeer Influenced and Corrupt Organizations Act, or RICO, the Connecticut ...
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results